» Articles » PMID: 30483794

MiR‑1271‑5p Inhibits Cell Proliferation and Induces Apoptosis in Acute Myeloid Leukemia by Targeting ZIC2

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2018 Nov 29
PMID 30483794
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) have been demonstrated to regulate the progression of numerous types of cancer, including acute myeloid leukemia (AML). Previous studies demonstrated that miR‑1271‑5p functions as a tumor suppressor; however, the roles of miR‑1271‑5p in AML remain unknown. In the present study, miR‑1271‑5p was significantly downregulated in AML tissues compared with normal tissues by reverse transcription‑quantitative polymerase chain reaction analysis. Furthermore, the expression levels of miR‑1271‑5p in patients with AML may function as a prognostic marker. In addition, overexpression of miR‑1271‑5p significantly suppressed the proliferation and induced apoptosis of AML cells by Cell Counting kit‑8 and fluorescence activated cell sorter assays; miR‑1271‑5p downregulation exhibited opposing effects. Additionally, transcription factor ZIC2 may be a direct target of miR‑1271‑5p in AML cells, which was demonstrated by a luciferase reporter assay and RNA pulldown assay. Overexpression of miR‑1271‑5p significantly reduced the mRNA and protein expression levels of ZIC2 in AML193 and OCI‑AML2 cells by reverse transcription‑quantitative polymerase chain reaction analysis and western blotting. Furthermore, an inverse correlation between miR‑1271‑5p and ZIC2 expression in AML samples was observed. In summary, ZIC2 was upregulated in AML tissues, and restoration of ZIC2 expression was able to promote the proliferation and reduce the apoptosis of AML cells transfected with miR‑1271‑5p mimics. The results of the present study demonstrated that miR‑1271‑5p inhibited the progression of AML by targeting ZIC2.

Citing Articles

MircoRNAs predict and modulate responses to chemotherapy in leukemic patients.

Ellakwa D, Abdelmalek M, Mostafa M, Ellakwa T, Wadan A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39808312 DOI: 10.1007/s00210-024-03675-7.


Functional mechanism and clinical implications of mir-1271-5p in pilon fracture healing processes.

Zhang Z, Wang L, Zhang F, Jing S, Cen M J Orthop Surg Res. 2024; 19(1):782.

PMID: 39578827 PMC: 11583746. DOI: 10.1186/s13018-024-05291-w.


MiR-1271-5p promotes the growth and migration of neuroblastoma cells by regulating ACY-1.

Sun J, Zhang X, Chen Z, Ye X, Zhang C Transl Cancer Res. 2024; 13(7):3397-3406.

PMID: 39145058 PMC: 11319971. DOI: 10.21037/tcr-24-25.


Evaluation of MicroRNA as Minimal Residual Disease in Leukemia: Diagnostic and Prognostic Approach: A Review.

Amiri B, Sabernia N, Abouali B, Amini P, Rezaeeyan H Iran J Public Health. 2024; 52(12):2541-2553.

PMID: 38435763 PMC: 10903317. DOI: 10.18502/ijph.v52i12.14315.


FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway.

Lv Z, Wang M, Hou H, Tang G, Xu H, Wang X Int J Biol Sci. 2023; 19(11):3293-3306.

PMID: 37496990 PMC: 10367559. DOI: 10.7150/ijbs.84067.


References
1.
Zebisch A, Hatzl S, Pichler M, Wolfler A, Sill H . Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs. Int J Mol Sci. 2016; 17(12). PMC: 5187880. DOI: 10.3390/ijms17122080. View

2.
Zhang T, Lin J, Zhou J, Li X, Zhang W, Guo H . High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia. Gene. 2017; 640:79-85. DOI: 10.1016/j.gene.2017.10.034. View

3.
Shen Z, Zhao K, Du T . HOXA10 promotes nasopharyngeal carcinoma cell proliferation and invasion via inducing the expression of ZIC2. Eur Rev Med Pharmacol Sci. 2017; 21(5):945-952. View

4.
Lu S, Zhang C, Luo R, Wang C, Liu L, Fu J . Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. Cancer Lett. 2017; 402:71-80. DOI: 10.1016/j.canlet.2017.05.018. View

5.
Estey E, Dohner H . Acute myeloid leukaemia. Lancet. 2006; 368(9550):1894-907. DOI: 10.1016/S0140-6736(06)69780-8. View